Maintenance of an intact intestinal epithelium is critical for intestinal growth, development, wound healing and prevention of disease. Restitution, the initial phase of epithelial wound repair, is regulated by a number of peptides, including cytokines such as tumor necrosis factor (TNF)alpha and epidermal growth (EGF). In spite a clear role for TNFalpha in the pathogenesis of inflammatory bowel disease, surprisingly little information is known about its role in the process of restitution. This proposal has evolved out of our long term studies on the mechanisms of growth factor regulated intestinal growth and development. Based on the synthesis of our preliminary and reported data, evidence from animal models of inflammatory bowel disease and on human clinical trials, the hypothesis being tested in this proposal is that TNFalpha specifically regulates intestinal epithelial restitution through signal transduction pathways required for cell migration and proliferation. We have established specific aims to address the following questions: (l) What are the principal mechanisms of TNFalpha regulation of intestinal epithelial cell migration? (2) What are the principal mechanisms of TNFalpha regulation of intestinal epithelial cell proliferation? and (3) How does TNFalpha interfere with EGF receptor signal transduction? To answer these questions we will use cellular transfection of the two human TNFalpha receptors (TNFalphaR1 and TNFalphaR2) and a series of constructs into the young adult mouse colon (YAMC) or mouse small intestinal epithelial (MSIE) cell lines. Using species-specific reagents we will investigate the function of TNFalphaR1 and TNFalphaR1 in the migration, proliferation and EGF receptor signal transduction of intestinal epithelial cells. Mutational analysis of the respective receptors will be used to determine regulatory domains effecting these processes. Once identified, regulatory domains will be placed in """"""""bait"""""""" plasmid constructs for screening in the yeast two-hybrid assay for interacting proteins. To enhance the likelihood of recovering functional interacting proteins, we will develop GST-fusion proteins using the domains to screen intestinal cell-derived cDNA libraries and for purification of proteins, from YAMC and MSIE cell lysates, for amino acid sequence analysis. Antibodies will be generated against novel proteins to characterize the nature and function of these protein-protein interactions. The proposed studies should enhance our understanding of mechanisms of cytokine regulation of epithelial restitution and the prioritization of signal transduction when multipleligands, such as TNFalpha and EGF, are simultaneously activating their cognate receptors. The findings will have broad implications on intestinal biology, from normal growth and development, to tumorigenesis and metastasis, to the chronic mucosal ulceration state of inflammatory bowel disease.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK056008-03
Application #
6381564
Study Section
General Medicine A Subcommittee 2 (GMA)
Program Officer
Hamilton, Frank A
Project Start
1999-08-15
Project End
2004-07-31
Budget Start
2001-08-01
Budget End
2002-07-31
Support Year
3
Fiscal Year
2001
Total Cost
$206,884
Indirect Cost
Name
Vanderbilt University Medical Center
Department
Pediatrics
Type
Schools of Medicine
DUNS #
004413456
City
Nashville
State
TN
Country
United States
Zip Code
37212
Dubé, Philip E; Liu, Cambrian Y; Girish, Nandini et al. (2018) Pharmacological activation of epidermal growth factor receptor signaling inhibits colitis-associated cancer in mice. Sci Rep 8:9119
Shen, Xi; Liu, Liping; Peek, Richard M et al. (2018) Supplementation of p40, a Lactobacillus rhamnosus GG-derived protein, in early life promotes epidermal growth factor receptor-dependent intestinal development and long-term health outcomes. Mucosal Immunol 11:1316-1328
Miguel, Jennifer C; Maxwell, Adrienne A; Hsieh, Jonathan J et al. (2017) Epidermal growth factor suppresses intestinal epithelial cell shedding through a MAPK-dependent pathway. J Cell Sci 130:90-96
Yan, F; Liu, L; Cao, H et al. (2017) Neonatal colonization of mice with LGG promotes intestinal development and decreases susceptibility to colitis in adulthood. Mucosal Immunol 10:117-127
Wang, Y; Liu, L; Moore, D J et al. (2017) An LGG-derived protein promotes IgA production through upregulation of APRIL expression in intestinal epithelial cells. Mucosal Immunol 10:373-384
Zhao, Gang; Liu, Liping; Peek Jr, Richard M et al. (2016) Activation of Epidermal Growth Factor Receptor in Macrophages Mediates Feedback Inhibition of M2 Polarization and Gastrointestinal Tumor Cell Growth. J Biol Chem 291:20462-72
Li, Ran; Zhang, Yufeng; Polk, D Brent et al. (2016) Preserving viability of Lactobacillus rhamnosus GG in vitro and in vivo by a new encapsulation system. J Control Release 230:79-87
Liu, Cambrian Y; Dubé, Philip E; Girish, Nandini et al. (2015) Optical reconstruction of murine colorectal mucosa at cellular resolution. Am J Physiol Gastrointest Liver Physiol 308:G721-35
Dubé, Philip E; Punit, Shivesh; Polk, D Brent (2015) Redeeming an old foe: protective as well as pathophysiological roles for tumor necrosis factor in inflammatory bowel disease. Am J Physiol Gastrointest Liver Physiol 308:G161-70
Punit, Shivesh; Dubé, Philip E; Liu, Cambrian Y et al. (2015) Tumor Necrosis Factor Receptor 2 Restricts the Pathogenicity of CD8(+) T Cells in Mice With Colitis. Gastroenterology 149:993-1005.e2

Showing the most recent 10 out of 54 publications